跳至主要内容
临床试验/JPRN-UMIN000039985
JPRN-UMIN000039985已完成未知

Disease control of patients with newly screening-detected hyperuricemia: A retrospective cohort study of health insurance claims and medical check-up data - Disease control of patients with newly screening-detected hyperuricemia

Teijin Pharma Limited0 个研究点目标入组 15,000 人开始时间: 2020年3月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
15,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who identified gout or asymptomatic hyperuricemia during the index period 2. Patients who received prescriptions of urate-lowering therapy during the index period 3. Patients who identified malignant neoplasms during the index period

研究者

相似试验